QA: Cartesian Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001453687_2023_Cartesian_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001453687, Cartesian Therapeutics Inc.

  xvar xval
0 AssetsCurrent 148,138,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,794,000
3 remainder_Assets 14,954,000
4 LiabilitiesCurrent 25,077,000
5 LiabilitiesNoncurrent 10,055,000
6 remainder_Liabilities 36,926,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,862,000
9 ResearchAndDevelopmentExpense 72,377,000
10 remainder_Expenses -18,460,000
11 remainder_Revenues 110,777,000
12 remainder_NetIncome 2,381,000
13 remainder_ComprehensiveNetIncome 8,000
  yvar yval
0 Assets 165,886,000
1 Liabilities 72,058,000
2 Expenses 77,779,000
3 Revenues 110,777,000
4 StockholdersEquity 93,828,000
5 NetIncome 35,379,000
6 ComprehensiveNetIncome 35,383,000
7 BaseVar 214,444,500
8 EconomicCapitalRatio 1.65

Edgar->Model Mapping

Feature Distribution

Change over Time